Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
8,093 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | EVER | EverQuote, Inc. | Canaccord Genuity | Main | Buy | Buy | Buy | 14 | $27.42 | -10.44% | 995.93M |
| Nov 3, 2026 | EVER | EverQuote, Inc. | Needham | Main | Buy | Buy | Buy | 14 | $27.42 | -10.44% | 995.93M |
| Nov 3, 2026 | EWBC | East West Bancorp, Inc. | Barclays | Main | Overweight | Overweight | — | — | $125.20 | -6.22% | 15.79B |
| Nov 3, 2026 | EXPE | Expedia Group, Inc. | UBS | Main | Neutral | Neutral | — | — | $231.91 | -28.09% | 32.89B |
| Nov 3, 2026 | FIGS | FIGS, Inc. | Barclays | Main | Overweight | Overweight | — | — | $15.00 | -32.52% | 1.91B |
| Nov 3, 2026 | FLG | Flagstar Financial, Inc. | Barclays | Main | Overweight | Overweight | Hold | 22 | $13.13 | +19.42% | 5.43B |
| Nov 3, 2026 | FLNC | Fluence Energy, Inc. | Goldman Sachs | Main | Neutral | Neutral | — | — | $15.75 | +163.11% | 3.39B |
| Nov 3, 2026 | FMC | FMC Corporation | Citigroup | Main | Neutral | Neutral | — | — | $23.14 | +259.32% | 1.71B |
| Nov 3, 2026 | FMC | FMC Corporation | UBS | Main | Neutral | Neutral | — | — | $23.14 | +259.32% | 1.71B |
| Nov 3, 2026 | FN | Fabrinet | Rosenblatt | Main | Buy | Buy | — | — | $524.50 | +57.08% | 18.93B |
| Nov 3, 2026 | FN | Fabrinet | Needham | Reiterated | Buy | Buy | — | — | $524.50 | +57.08% | 18.93B |
| Nov 3, 2026 | FOX | Fox Corporation | JP Morgan | Main | Overweight | Overweight | Buy | 28 | $82.00 | +32.82% | 28.65B |
| Nov 3, 2026 | FRST | Primis Financial Corp. | Keefe, Bruyette & Woods | Main | Outperform | Outperform | Buy | 8 | $14.00 | -7.41% | 316.62M |
| Nov 3, 2026 | FTI | TechnipFMC plc | Piper Sandler | Main | Overweight | Overweight | — | — | $47.50 | -25.85% | 19.38B |
| Nov 3, 2026 | GEV | GE Vernova Inc. | Argus Research | Main | Buy | Buy | Buy | 23 | $726.62 | -11.13% | 191.08B |
| Nov 3, 2026 | HII | Huntington Ingalls Industries, Inc. | Bernstein | Main | Market Perform | Market Perform | — | — | $327.33 | +8.89% | 12.82B |
| Nov 3, 2026 | HII | Huntington Ingalls Industries, Inc. | JP Morgan | Main | Neutral | Neutral | — | — | $327.33 | +8.89% | 12.82B |
| Nov 3, 2026 | HIPO | Hippo Holdings Inc. | Keefe, Bruyette & Woods | Main | Market Perform | Market Perform | — | — | $45.00 | +26.83% | 772.8M |
| Nov 3, 2026 | HLIT | Harmonic Inc. | Barclays | Main | Equal-Weight | Equal-Weight | — | — | $11.00 | +10.78% | 1.23B |
| Nov 3, 2026 | HLIT | Harmonic Inc. | Rosenblatt | Main | Buy | Buy | — | — | $11.00 | +10.78% | 1.23B |
| Nov 3, 2026 | HLT | Hilton Worldwide Holdings Inc. | Citigroup | Main | Neutral | Neutral | Buy | 16 | $281.00 | -24.71% | 64.66B |
| Nov 3, 2026 | HNGE | Hinge Health, Inc. | Evercore ISI Group | Main | Outperform | Outperform | — | — | $57.63 | -51.93% | 3.93B |
| Nov 3, 2026 | HNGE | Hinge Health, Inc. | Stifel | Main | Buy | Buy | — | — | $57.63 | -51.93% | 3.93B |
| Nov 3, 2026 | HNGE | Hinge Health, Inc. | Canaccord Genuity | Main | Buy | Buy | — | — | $57.63 | -51.93% | 3.93B |
| Nov 3, 2026 | HNGE | Hinge Health, Inc. | Needham | Main | Buy | Buy | — | — | $57.63 | -51.93% | 3.93B |
| Nov 3, 2026 | HWM | Howmet Aerospace Inc. | Keybanc | Upgrade | Sector Weight | Overweight | Buy | 14 | $223.71 | +4.91% | 78.85B |
| Nov 3, 2026 | IBTA | Ibotta, Inc. | Evercore ISI Group | Main | In-Line | In-Line | — | — | $26.00 | -57.85% | 517.91M |
| Nov 3, 2026 | IBTA | Ibotta, Inc. | Wells Fargo | Main | Equal-Weight | Equal-Weight | — | — | $26.00 | -57.85% | 517.91M |
| Nov 3, 2026 | IBTA | Ibotta, Inc. | Needham | Main | Buy | Buy | — | — | $26.00 | -57.85% | 517.91M |
| Nov 3, 2026 | ICHR | Ichor Holdings, Ltd. | B. Riley Securities | Main | Buy | Buy | — | — | $25.33 | -25.76% | 642.13M |
| Nov 3, 2026 | ICHR | Ichor Holdings, Ltd. | Stifel | Main | Buy | Buy | — | — | $25.33 | -25.76% | 642.13M |
| Nov 3, 2026 | ICHR | Ichor Holdings, Ltd. | Needham | Main | Buy | Buy | — | — | $25.33 | -25.76% | 642.13M |
| Nov 3, 2026 | ICHR | Ichor Holdings, Ltd. | TD Cowen | Main | Buy | Buy | — | — | $25.33 | -25.76% | 642.13M |
| Nov 3, 2026 | IDA | IDACORP, Inc. | Barclays | Main | Overweight | Overweight | — | — | $143.80 | -2.51% | 6.8B |
| Nov 3, 2026 | IDXX | IDEXX Laboratories, Inc. | Morgan Stanley | Main | Overweight | Overweight | Hold | 8 | $803.57 | +12.83% | 56.52B |
| Nov 3, 2026 | IDXX | IDEXX Laboratories, Inc. | UBS | Main | Neutral | Neutral | Hold | 8 | $803.57 | +12.83% | 56.52B |
| Nov 3, 2026 | IMSR | Terrestrial Energy Inc. | Wedbush | Initiated | — | Neutral | — | — | — | — | 787.05M |
| Nov 3, 2026 | INVH | Invitation Homes Inc. | Evercore ISI Group | Main | Outperform | Outperform | — | — | $32.83 | +19.58% | 16.29B |
| Nov 3, 2026 | IOVA | Iovance Biotherapeutics, Inc. | UBS | Main | Neutral | Neutral | — | — | $14.25 | +66.76% | 744.64M |
| Nov 3, 2026 | KMI | Kinder Morgan, Inc. | Morgan Stanley | Main | Equal-Weight | Equal-Weight | Hold | 12 | $30.00 | -4.91% | 59.61B |
| Nov 3, 2026 | KRYS | Krystal Biotech, Inc. | RBC Capital | Main | Outperform | Outperform | Buy | 18 | $220.00 | -29.35% | 7.16B |
| Nov 3, 2026 | KRYS | Krystal Biotech, Inc. | Citigroup | Main | Buy | Buy | Buy | 18 | $220.00 | -29.35% | 7.16B |
| Nov 3, 2026 | KRYS | Krystal Biotech, Inc. | TD Cowen | Main | Buy | Buy | Buy | 18 | $220.00 | -29.35% | 7.16B |
| Nov 3, 2026 | LASR | nLIGHT, Inc. | Needham | Main | Buy | Buy | — | — | $40.00 | +20.72% | 1.89B |
| Nov 3, 2026 | LEN | Lennar Corporation | Morgan Stanley | Main | Underweight | Underweight | Hold | 23 | $121.75 | +31.33% | 30.38B |
| Nov 3, 2026 | LEN-B | Lennar Corporation | Morgan Stanley | Main | Underweight | Underweight | Hold | 23 | $96.75 | +5.68% | 29.54B |
| Nov 3, 2026 | LHX | L3Harris Technologies, Inc. | B of A Securities | Main | Buy | Buy | Buy | 11 | $325.00 | +25.13% | 54.23B |
| Nov 3, 2026 | LIFE | aTyr Pharma, Inc. | Citizens | Main | Market Outperform | Market Outperform | — | — | $11.00 | -71.33% | 131.12M |
| Nov 3, 2026 | LIFE | aTyr Pharma, Inc. | Barclays | Main | Overweight | Overweight | — | — | $11.00 | -71.33% | 131.12M |
| Nov 3, 2026 | LIFE | aTyr Pharma, Inc. | Baird | Main | Outperform | Outperform | — | — | $11.00 | -71.33% | 131.12M |
